Angela C Webster

Summary

Publications

  1. doi request reprint Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting)
    Angela C Webster
    School of Public Health, University of Sydney, New South Wales, Australia
    Nephrology (Carlton) 15:491-501. 2010
  2. ncbi request reprint Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients
    A C Webster
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Children s Hospital at Westmead, NSW, Australia
    Am J Transplant 7:2140-51. 2007
  3. ncbi request reprint The CARI guidelines. Calcineurin inhibitors in renal transplantation: the addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients
    Angela C Webster
    Department of Renal Medicine, Royal Infirmary of Edinburgh, Old Dalkeith Road, Edinburgh EH16 4SY, UK
    Nephrology (Carlton) 12:S75-84. 2007
  4. ncbi request reprint Managing cancer risk and decision making after kidney transplantation
    A C Webster
    School of Public Health, University of Sydney, Westmead Hospital, NSW Australia
    Am J Transplant 8:2185-91. 2008
  5. ncbi request reprint Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials
    Angela C Webster
    Cochrane Renal Group, Children s Hospital at Westmead, Westmead, and School of Public Health, University of Sydney, Sydney, Australia
    Transplantation 81:1234-48. 2006
  6. ncbi request reprint How to get the most from the medical literature: searching the medical literature effectively
    Angela C Webster
    Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia
    Nephrology (Carlton) 15:12-9. 2010
  7. pmc Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study
    Marina T van Leeuwen
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria St, Sydney, NSW, 2010, Australia
    BMJ 340:c570. 2010
  8. doi request reprint Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation
    Marina T van Leeuwen
    National Centre in HIV Epidemiology and Clinical Research, and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Blood 114:630-7. 2009
  9. doi request reprint Immunosuppression and other risk factors for lip cancer after kidney transplantation
    Marina T van Leeuwen
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
    Cancer Epidemiol Biomarkers Prev 18:561-9. 2009
  10. ncbi request reprint Acute rejection, T-cell-depleting antibodies, and cancer after transplantation
    Wai H Lim
    1 Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia 2 Sydney School of Public Health, University of Sydney, New South Wales, Australia 3 Centre for Transplant and Renal Research, Westmead Hospital, New South Wales, Australia 4 Department of Medicine, Queen Mary Hospital, Hong Kong 5 Centre for Kidney Research, The Children s Hospital at Westmead, New South Wales, Australia 6 Address correspondence to Wai H Lim, MBBS, PhD, FRACP, Department of Renal Medicine, Sir Charles Gairdner Hospital, Hospital Avenue, Perth, Australia 6009
    Transplantation 97:817-25. 2014

Collaborators

Detail Information

Publications60

  1. doi request reprint Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting)
    Angela C Webster
    School of Public Health, University of Sydney, New South Wales, Australia
    Nephrology (Carlton) 15:491-501. 2010
    ..We assessed agreement between incident cancer reported to the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA) and to the Central Cancer Registry (CCR) in New South Wales...
  2. ncbi request reprint Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients
    A C Webster
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Children s Hospital at Westmead, NSW, Australia
    Am J Transplant 7:2140-51. 2007
    ..Men aged 45-54 surviving 10 years have cancer risks varying from 1 in 13 (non-white, no prior cancer, diabetic ESKD) to 1 in 5 (white, prior cancer, other ESKD)...
  3. ncbi request reprint The CARI guidelines. Calcineurin inhibitors in renal transplantation: the addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients
    Angela C Webster
    Department of Renal Medicine, Royal Infirmary of Edinburgh, Old Dalkeith Road, Edinburgh EH16 4SY, UK
    Nephrology (Carlton) 12:S75-84. 2007
  4. ncbi request reprint Managing cancer risk and decision making after kidney transplantation
    A C Webster
    School of Public Health, University of Sydney, Westmead Hospital, NSW Australia
    Am J Transplant 8:2185-91. 2008
    ....
  5. ncbi request reprint Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials
    Angela C Webster
    Cochrane Renal Group, Children s Hospital at Westmead, Westmead, and School of Public Health, University of Sydney, Sydney, Australia
    Transplantation 81:1234-48. 2006
    ..We performed a systematic review of randomized trials where immunosuppressive regimens containing TOR-I were compared with other regimens as initial therapy for kidney transplant recipients...
  6. ncbi request reprint How to get the most from the medical literature: searching the medical literature effectively
    Angela C Webster
    Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia
    Nephrology (Carlton) 15:12-9. 2010
    ..We illustrate these with sensitive and specific search strategies to answer different clinical questions arising from a hypothetical clinical scenario typical of a nephrologist's everyday practice...
  7. pmc Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study
    Marina T van Leeuwen
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria St, Sydney, NSW, 2010, Australia
    BMJ 340:c570. 2010
    ..Incident cancers were ascertained using linkage with national cancer registry records...
  8. doi request reprint Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation
    Marina T van Leeuwen
    National Centre in HIV Epidemiology and Clinical Research, and School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Blood 114:630-7. 2009
    ..These findings support 2 mechanisms of lymphomagenesis, one predominantly of primary EBV infection in the context of intense immunosuppression, and another of dysregulated lymphoid proliferation in a prolonged immunosuppressed state...
  9. doi request reprint Immunosuppression and other risk factors for lip cancer after kidney transplantation
    Marina T van Leeuwen
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
    Cancer Epidemiol Biomarkers Prev 18:561-9. 2009
    ..During transplant function, lip cancer risk is associated with the duration of immunosuppression, receipt of specific immunosuppressive agents, and UV exposure...
  10. ncbi request reprint Acute rejection, T-cell-depleting antibodies, and cancer after transplantation
    Wai H Lim
    1 Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia 2 Sydney School of Public Health, University of Sydney, New South Wales, Australia 3 Centre for Transplant and Renal Research, Westmead Hospital, New South Wales, Australia 4 Department of Medicine, Queen Mary Hospital, Hong Kong 5 Centre for Kidney Research, The Children s Hospital at Westmead, New South Wales, Australia 6 Address correspondence to Wai H Lim, MBBS, PhD, FRACP, Department of Renal Medicine, Sir Charles Gairdner Hospital, Hospital Avenue, Perth, Australia 6009
    Transplantation 97:817-25. 2014
    ..We aimed to determine the association between acute rejection, T-cell-depleting antibody use and cancer risk after kidney transplantation...
  11. doi request reprint Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials
    Lorna K Henderson
    Cochrane Renal Group, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
    Am J Kidney Dis 61:74-87. 2013
    ..Treatment regimens combining cyclophosphamide with steroids preserve kidney function but have significant side effects. Newer immunosuppressive agents may have improved toxicity profiles...
  12. pmc Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities
    Germaine Wong
    Centre for Kidney Research, Children s Hospital at Westmead, Westmead, Australia
    PLoS ONE 7:e29591. 2012
    ..The aim of our study is to estimate the average and incremental survival benefits and health care costs of listing and transplantation compared to dialysis among individuals with varying co-morbidities...
  13. doi request reprint Time on dialysis and cancer risk after kidney transplantation
    Germaine Wong
    Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia
    Transplantation 95:114-21. 2013
    ..We aimed to determine if the length of time on maintenance dialysis before the first kidney transplantation was associated with the risk of site-specific and overall incident cancers after transplantation...
  14. ncbi request reprint Cancer incidence before and after kidney transplantation
    Claire M Vajdic
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    JAMA 296:2823-31. 2006
    ..Although it is generally accepted that other cancers do not occur at increased rates, there have been few long-term population-based cohort studies performed...
  15. doi request reprint Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
    Elisabeth M Hodson
    Centre for Kidney Research, The Children s Hospital at Westmead, Westmead, Australia
    Cochrane Database Syst Rev 2:CD003774. 2013
    ..This is an update of a review first published in 2005 and updated in 2008...
  16. doi request reprint Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study
    Rachael L Morton
    Sydney School of Public Health, The University of Sydney, NSW, Australia
    Am J Kidney Dis 60:102-11. 2012
    ..Dialysis modality preferences of patients with chronic kidney disease (CKD) and family caregivers are important, yet rarely quantified...
  17. pmc Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease
    Rachael L Morton
    Sydney School of Public Health, The University of Sydney, Sydney, Australia
    CMAJ 184:E277-83. 2012
    ..We aimed to determine the most important characteristics of dialysis and the trade-offs patients were willing to make in choosing dialysis instead of conservative care...
  18. doi request reprint Patient INformation about Options for Treatment (PINOT): a prospective national study of information given to incident CKD Stage 5 patients
    Rachael L Morton
    Sydney School of Public Health, The University of Sydney, Sydney, Australia
    Nephrol Dial Transplant 26:1266-74. 2011
    ..The aim of this study was to determine the effect of patient and unit characteristics on the type and timing of information provided...
  19. ncbi request reprint Relative energy balance, CKD, and risk of cardiovascular and all-cause mortality
    Samuel Iff
    Centre for Kidney Research, Kids Research Institute, Children s Hospital at Westmead, Sydney, Australia Institute for Social and Preventive Medicine, University Bern, Bern, Switzerland Electronic address
    Am J Kidney Dis 63:437-45. 2014
    ..Higher body mass index, generally due to higher energy intake, appears protective for people on dialysis therapy, but the relationship between energy intake and survival in those with reduced kidney function is unknown...
  20. ncbi request reprint Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data
    Angela C Webster
    Cochrane Renal Group, Children s Hospital, Westmead, New South Wales, Australia
    Transplantation 81:953-65. 2006
    ..We performed a comprehensive systematic review to determine the relative benefits and harms of widely used interventions used to treat acute rejection in kidney transplant recipients: monoclonal or polyclonal antibodies (Ab)...
  21. doi request reprint No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency
    Claire M Vajdic
    UNSW Cancer Research Centre, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia
    Int J Cancer 127:2732-5. 2010
    ..82, 95% CI: 0.10-2.96) and in people with HIV (SIR 1.25, 95% CI: 0.41-2.91). The findings argue against an infectious or other immunodeficiency-related etiology for FL and clearly differentiate it from diffuse large B-cell lymphoma...
  22. ncbi request reprint Cardiac testing for coronary artery disease in potential kidney transplant recipients
    Louis W Wang
    Department of Cardiology, St Vincent s Hospital, Darlinghurst, NSW, Australia, 2010
    Cochrane Database Syst Rev 12:CD008691. 2011
    ..There is significant interest in the role of non-invasive cardiac investigations and their ability to identify patients at high risk of CAD. ..
  23. pmc Association of CKD and cancer risk in older people
    Germaine Wong
    National Health and Medical Research Council Centre for Clinical Research Excellence in Renal Medicine, Children s Hospital at Westmead, Westmead, New South Wales, Australia
    J Am Soc Nephrol 20:1341-50. 2009
    ..In conclusion, moderate CKD (stage 3) may be an independent risk factor for the development of cancer among older men but not women, and the effect of CKD on risk may vary for different types of cancer...
  24. doi request reprint Tests for latent tuberculosis in people with ESRD: a systematic review
    Thomas E Rogerson
    Centre for Kidney Research, The Children s Hospital at Westmead, Westmead, Australia
    Am J Kidney Dis 61:33-43. 2013
    ..TB tests, respectively) and the tuberculin skin test (TST) for latent tuberculosis (TB) infection in people with end-stage kidney disease is uncertain and national guidelines for their use are inconsistent...
  25. doi request reprint Screening for renal cancer in recipients of kidney transplants
    Germaine Wong
    Centre for Kidney Research, The Children s Hospital at Westmead, NSW, Australia
    Nephrol Dial Transplant 26:1729-39. 2011
    ..It is uncertain whether routine screening for renal cancer is cost-effective. The aim of our study is to estimate the costs and health benefits of ultrasonographic (US) screening for renal cancer in the kidney transplant population...
  26. doi request reprint The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies
    Allison Tong
    Centre for Kidney Research, The Children s Hospital at Westmead, Westmead, NSW 2145, Australia
    Nephrol Dial Transplant 26:344-54. 2011
    ..This study aimed to describe the beliefs, experiences and perspectives of kidney transplant recipients on medicine taking...
  27. pmc Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
    Angela C Webster
    Cochrane Renal Group, Centre for Kidney Research, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
    BMJ 331:810. 2005
    ..To compare the positive and negative effects of tacrolimus and ciclosporin as initial treatment for renal transplant recipients...
  28. ncbi request reprint How is Health Economics Relevant to Transplant Clinicians?
    Germaine Wong
    1 Centre for Kidney Research, The Children s Hospital at Westmead 2 Sydney School of Public Health, University of Sydney, Sydney 3 Centre for Transplant and Renal Research, Westmead Hospital, NSW, Australia 4 Address correspondence to Germaine Wong, Ph D, Centre for Transplant and Renal Research, Westmead Hospital, Westmead 2145, NSW, Australia
    Transplantation 98:124-30. 2014
    ..This article is an overview of the concepts of economic evaluation in the setting of transplantation and highlights the applicability of these concepts in clinical transplantation. ..
  29. doi request reprint Characteristics of dialysis important to patients and family caregivers: a mixed methods approach
    Rachael L Morton
    Sydney School of Public Health, The University of Sydney, Sydney, Australia
    Nephrol Dial Transplant 26:4038-46. 2011
    ..The aim of this study was to rank the most important characteristics of dialysis on which patients and caregivers make decisions about treatment...
  30. doi request reprint Trial registration and declaration of registration by authors of randomized controlled trials
    Richard G McGee
    Centre for Kidney Research and Cochrane Renal Group, The Children s Hospital at Westmead, Westmead, NSW, Australia
    Transplantation 92:1094-100. 2011
    ..Trial registration was introduced to reduce research bias by promoting trial transparency and accountability. We aimed to evaluate the frequency of, and factors associated with, trial registration and declaration of trial registration...
  31. doi request reprint Diagnostic test studies in nephrology: quantity, quality, and scope
    Richard G McGee
    Centre for Kidney Research and Cochrane Renal Group, The Children s Hospital at Westmead, Westmead, NSW, Australia
    Am J Kidney Dis 58:921-7. 2011
    ..We hypothesized that diagnostic errors are reduced through evidence-based choice, use, and interpretation of diagnostic tests...
  32. ncbi request reprint Patient information about options for treatment: Methods of a national audit of information provision in chronic kidney disease
    Rachael L Morton
    University of Sydney, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Australia
    Nephrology (Carlton) 15:649-52. 2010
    ..PINOT will assess the patient and unit characteristics associated with timely information provision and highlight any regional variation in treatments offered...
  33. ncbi request reprint Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials
    Angela C Webster
    Cochrane Renal Group, Centre for Kidney Research, Children s Hospital at Westmead, Westmead, NSW, Australia
    Transplantation 77:166-76. 2004
    ..This study aims to systematically identify and summarize the effects of using IL-2Ra as induction immunosuppression, as an addition to standard therapy, or as an alternative to other antibody therapy...
  34. doi request reprint Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials
    Nicholas B Cross
    Centre for Kidney Research, Children s Hospital at Westmead, Westmead, NSW, Australia
    Transplantation 88:7-18. 2009
    ..2-15.8), and increased hyperkalemia (RR 3.7, 95% CI 1.9-7.7). Graft loss data were inconclusive (RR 7.4, 95% CI 0.4-140). These data suggest that CCB may be preferred as first-line agents for hypertensive kidney transplant recipients...
  35. ncbi request reprint Asking the right question and finding the right answers
    Nicholas B Cross
    Centre for Kidney Research, Children s Hospital at Westmead, New South Wales, Australia
    Nephrology (Carlton) 15:8-11. 2010
    ..We describe a method for rephrasing or 'framing' clinical questions into population, intervention, comparator and outcome terms that helps to determine the best type of study to search for, and aids in the design of search strategies...
  36. pmc Long-term cancer risk of immunosuppressive regimens after kidney transplantation
    Martin P Gallagher
    Renal Division, George Institute for International Health, Camperdown, New South Wales, Australia
    J Am Soc Nephrol 21:852-8. 2010
    ..In conclusion, these immunosuppressive regimens, widely used in recent decades, carry similar risks for carcinogenicity after kidney transplantation...
  37. ncbi request reprint Diagnostic accuracy of blood qualitative nucleic acid testing for polyomavirus-associated nephropathy in kidney recipients
    Nicholas B Cross
    Centre for Kidney Research, Children s Hospital at Westmead, Westmead, NSW 2145, Australia
    Nephrology (Carlton) 14:350-6. 2009
    ....
  38. doi request reprint The cost-effectiveness of induction immunosuppression in kidney transplantation
    Rachael L Morton
    School of Public Health, The University of Sydney, Sydney, NSW, Australia
    Nephrol Dial Transplant 24:2258-69. 2009
    ..This study evaluated the cost-effectiveness of antibody induction comparing interleukin-2 receptor antagonists (IL2Ra) to standard therapy with no induction or induction with polyclonal antibodies...
  39. doi request reprint Reported cancer screening practices of nephrologists: results from a national survey
    Germaine Wong
    NHMRC Centre for Clinical Research Excellence in Renal Medicine, Children s Hospital at Westmead, NSW, Australia
    Nephrol Dial Transplant 24:2136-43. 2009
    ..This study aimed to describe cancer screening practices by nephrologists in Australia and New Zealand, and to identify reasons for a positive recommendation to screen...
  40. doi request reprint Treatment for lupus nephritis
    Lorna Henderson
    Centre for Transplant and Renal Research, Westmead Millennium Institute, The University of Sydney at Westmead, Westmead, Australia
    Cochrane Database Syst Rev 12:CD002922. 2012
    ..Several new agents, including mycophenolate mofetil (MMF), suggest reduced toxicity with equivalent rates of remission. This is an update of a Cochrane review first published in 2004...
  41. doi request reprint Patients who plan for conservative care rather than dialysis: a national observational study in Australia
    Rachael L Morton
    School of Public Health, The University of Sydney, Australia
    Am J Kidney Dis 59:419-27. 2012
    ..It is unclear how many incident patients with stage 5 chronic kidney disease (CKD) referred to nephrologists are presented with information about conservative care as a treatment option and how many plan not to dialyze...
  42. ncbi request reprint Antibiotics for acute pyelonephritis in children
    Yvonne Strohmeier
    Westmead Clinical School, University of Sydney, Cnr Darcy Rd and Hawksbury Rd, Westmead, NSW, Australia, 2145
    Cochrane Database Syst Rev 7:CD003772. 2014
    ..There remains uncertainty regarding the optimum antibiotic regimen, route of administration and duration of treatment. This is an update of a review that was first published in 2003 and updated in 2005 and 2007...
  43. doi request reprint Systematic reviews of surgical procedures in children: quantity, coverage and quality
    Richard G McGee
    Centre for Kidney Research and Cochrane Renal Group, The Children s Hospital at Westmead, New South Wales, Australia
    J Paediatr Child Health 49:319-24. 2013
    ..We aimed to describe and evaluate the quantity, coverage and the quality of conduct and reporting of systematic reviews of surgical procedures in children...
  44. doi request reprint How to write a Cochrane systematic review
    Lorna K Henderson
    Centre for Kidney Research, Children s Hospital at Westmead Centre for Transplant and Renal Research, Westmead Millennium Institute, University of Sydney at Westmead Hospital Sydney School of Public Health, New South Wales, Australia
    Nephrology (Carlton) 15:617-24. 2010
    ..Here we aim to describe the steps involved to undertake a new or update an existing Cochrane Review...
  45. doi request reprint Expanding the evidence base in transplantation: more and better randomized trials, and extending the value of observational data
    Jonathan C Craig
    Screening and Diagnostic Test Evaluation Program, School of Public Health, University of Sydney, Sydney, NSW, Australia
    Transplantation 86:32-5. 2008
    ....
  46. ncbi request reprint How to read a report of a randomized controlled trial
    Min Jun
    The George Institute for International Health, The University of Sydney, PO Box 201, Missenden Road, Sydney, NSW 2050, Australia
    Nephrology (Carlton) 15:153-7. 2010
    ..This paper aims to explain how to approach critical appraisal, by highlighting and illustrating important questions that help determine the reliability of results from randomized trials...
  47. doi request reprint Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies
    Louis W Wang
    Sydney School of Public Health, University of Sydney, Sydney, Australia
    Am J Kidney Dis 57:476-87. 2011
    ..Cardiovascular disease is the leading cause of death after kidney transplant. Screening for coronary artery disease is integral to pretransplant evaluation, although the relative performance of different tests is uncertain...
  48. ncbi request reprint Medical device regulation in Australia: safe and effective?
    Richard G McGee
    Sydney School of Public Health, University of Sydney, Sydney, NSW
    Med J Aust 196:256-60. 2012
    ..To describe the frequency, characteristics and outcomes of reports of possible harms related to medical devices submitted to the Australian Therapeutic Goods Administration (TGA) using data made publicly available on the TGA website...
  49. ncbi request reprint Parenteral versus oral iron therapy for adults and children with chronic kidney disease
    Jumana Albaramki
    Centre for Kidney Research, The Children sHospital atWestmead, Westmead, Australia
    Cochrane Database Syst Rev 1:CD007857. 2012
    ..Iron can be provided through different routes, with advantages and drawbacks of each route. It remains unclear whether the potential harms and additional costs of intravenous (IV) compared with oral iron are justified...
  50. doi request reprint How many patients do we need for a clinical trial? Demystifying sample size calculations
    Patrick J Kelly
    University of Sydney, Sydney, Australia
    Nephrology (Carlton) 15:725-31. 2010
    ..The primary aim is to demystify the sample size section in published clinical trials. Some of the difficulties in determining the sample size correctly are also highlighted and some good practices recommended...
  51. ncbi request reprint Proton pump inhibitors and acute interstitial nephritis
    Nimeshan Geevasinga
    University of Sydney, Sydney, and Department of Medicine, Manly Hospital, Australia
    Clin Gastroenterol Hepatol 4:597-604. 2006
    ..The aim of this study was to investigate how widespread this complication is in Australia, to identify which PPIs are implicated, and to establish whether PPI-induced AIN is a class effect...
  52. ncbi request reprint Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials
    Elisabeth M Hodson
    National Health and Medical Research Council Centre for Clinical Research Excellence, Centre for Kidney Research, The Children s Hospital at Westmead, Sydney, Australia
    Lancet 365:2105-15. 2005
    ..We undertook a systematic review to investigate whether this approach affects risks of cytomegalovirus disease and death...
  53. doi request reprint Meta-analyses in prevention and treatment of urinary tract infections
    Philip Masson
    Department of Renal Medicine, Royal Infirmary of Edinburgh, Scotland, UK
    Infect Dis Clin North Am 23:355-85; Table of Contents. 2009
    ..Suggestions are made for future research, because it is apparent that there are evidence gaps for particular subgroups of people...
  54. doi request reprint Interventions for the symptoms and signs resulting from jellyfish stings
    Li Li
    Sydney School of Medicine, The University of Sydney, Edward Ford Building, A27, Sydney, NSW, Australia, 2006
    Cochrane Database Syst Rev 12:CD009688. 2013
    ..Many treatments have been suggested for the symptoms and signs of jellyfish stings. However, it is unclear which interventions are most effective...
  55. ncbi request reprint Probiotics for patients with hepatic encephalopathy
    Richard G McGee
    Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia, 2006
    Cochrane Database Syst Rev 11:CD008716. 2011
    ..Probiotics are live microorganisms, which when administered in adequate amounts may confer a health benefit on the host...
  56. ncbi request reprint How to get the most from the medical literature: keeping up to date in nephrology
    Jeremy Cullis
    Medical Sciences Libraries and School of Public Health, University of Sydney, Sydney, Australia
    Nephrology (Carlton) 15:269-76. 2010
    ..In this paper we will examine Web 2.0, including the use of RSS, and suggest a number of different websites that offer free access to nephrology news...
  57. pmc The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies
    R L Morton
    Sydney School of Public Health, University of Sydney, Sydney, NSW 2006, Australia
    BMJ 340:c112. 2010
    ..To synthesise the views of patients and carers in decision making regarding treatment for chronic kidney disease, and to determine which factors influence those decisions...
  58. pmc Sirolimus is associated with new-onset diabetes in kidney transplant recipients
    Olwyn Johnston
    Division of Nephrology, St Paul s Hospital, University of British Columbia, 1081 Burrard Street, Vancouver, BC, Canada
    J Am Soc Nephrol 19:1411-8. 2008
    ..Given the negative impact of NOD on posttransplantation outcomes, these findings should be confirmed in prospective studies or in meta-analyses of existing trials that involved sirolimus...
  59. ncbi request reprint Increased incidence of squamous cell carcinoma of eye after kidney transplantation
    Claire M Vajdic
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2 376 Victoria St, Darlinghurst NSW 2010, Australia
    J Natl Cancer Inst 99:1340-2. 2007
    ..Our data also support an interaction between immune suppression and sun exposure in the development of ocular SCC after kidney transplantation...
  60. ncbi request reprint Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials
    E Geoffrey Playford
    Infection Management Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia
    J Antimicrob Chemother 57:628-38. 2006
    ..This study aims to systematically identify and summarize the effects of antifungal prophylaxis in non-neutropenic critically ill adult patients on all-cause mortality and the incidence of invasive fungal infections...